How to Find a Haircare Chemist for Scalp Microbiome Products

What regulatory requirements apply to scalp microbiome haircare products?

By Blake Mereby · Last reviewed October 13, 2026

Scalp microbiome haircare products occupy a complex regulatory space that varies significantly by region. In the United States, the FDA classifies haircare products as cosmetics if they are intended to cleanse, beautify, or condition hair or scalp without making therapeutic claims; however, if the product claims to prevent, treat, or cure any disease or condition affecting the scalp (such as dandruff, seborrheic dermatitis, or microbiome imbalance), the FDA may classify it as a drug, which triggers significantly more stringent requirements including a New Drug Application (NDA) or compliance with an applicable OTC drug monograph. The distinction hinges on the language used in your marketing, on your ingredient list, and on what clinical evidence you present. A shampoo labeled "supports scalp health" is likely a cosmetic; one labeled "treats dandruff" or "prevents malassezia overgrowth" is likely a drug.

In the European Union, cosmetics are regulated under the EU Cosmetics Regulation (EC 1223/2009), which permits a wider range of non-medicinal claims than the US FDA allows. A scalp microbiome product can make structure/function claims (e.g., "supports the scalp microbiome," "maintains scalp flora balance") without triggering drug classification, provided it does not claim to treat disease. The EU prohibited ingredients list is extensive and regularly updated; some actives you might use (such as certain zinc compounds or herbal antimicrobials) may be restricted or require special approval. All cosmetics sold in the EU must be registered in the Cosmetics Products Notification and Monitoring System (CPNMS) and listed on the CPNP (Cosmetics Products Notification Portal), a requirement that takes 1–2 months and involves submitting safety assessments, ingredient declarations, and product information.

Canada's Therapeutic Products Directorate (TPD) and Natural and Non-prescription Health Products Directorate (NNHPD) regulate haircare products similarly to the US: if a product makes health claims, it may be classified as a natural health product (NHP) or drug, requiring licensing before sale. A prebiotic shampoo without therapeutic claims is a cosmetic, but one claiming to "restore the healthy scalp microbiome" or to prevent scalp infections may require NHP or drug licensing.

Australia's Therapeutic Goods Administration (TGA) classifies scalp products as cosmetics or therapeutic goods depending on claimed purpose; therapeutic goods require TGA registration and evidence of efficacy and safety. The UK post-Brexit follows similar cosmetics requirements to the EU but also accepts some alternative safety assessment pathways; importing cosmetics from the EU is possible but requires UK compliance.

For scalp microbiome products with live probiotics or postbiotics, additional layers of scrutiny apply. The FDA considers live microorganisms (such as Vitreoscilla or Bacillus ferments) to be food additives or ingredients requiring safety documentation; many probiotics for topical use lack FDA approval, so their legal status in a US cosmetic or drug product is ambiguous. The EU permits certain microorganisms in cosmetics if they are properly documented and safe, but novel strains or those with unclear safety profiles may face pushback. Canada is similarly cautious. Your formulation chemist should research the regulatory history of any probiotic strain you plan to use; some strains (such as Lactobacillus) have more established cosmetic use and are less likely to trigger regulatory questions than novel ferments.

Safety and stability testing requirements also vary. In the US, a cosmetic must be safe under intended use, and you should have safety data on file (ingredient safety literature, stability data, and often a Stability Program or Shelf-Life study). The FDA does not pre-approve cosmetics, but it can issue warning letters or enforce recalls if a product is found to be unsafe or misbranded. The EU requires a safety assessment by a qualified toxicologist; this assessment must be submitted to the CPNMS and covers safety evaluation of the finished product and all raw materials. Scalp microbiome products often warrant accelerated stability testing (e.g., 8–12 weeks at 40 °C and 75% relative humidity) to model real-world shelf-life and to document that probiotic viability or prebiotic efficacy is maintained over the product's claimed shelf-life. This testing costs $2,000–$5,000 and is non-negotiable if you are making any efficacy or stability claims.

Claim substantiation is critical. If you claim that your product "supports the scalp microbiome," you should have evidence (in-vitro studies, clinical testing, or published literature) that supports that claim. In the US, the Federal Trade Commission (FTC) requires that all advertising claims be backed by competent and reliable scientific evidence; making unsupported microbiome claims risks FTC action for unfair or deceptive advertising. The EU's SCCS (Scientific Committee on Consumer Safety) and similar bodies scrutinize efficacy claims, and while they are generally more permissive of structure/function claims than the FDA, they still require substantiation. A common mistake is making broad microbiome-balancing claims without clinical or in-vitro data; if you do, budget $5,000–$20,000 for a third-party clinical or microbial testing study to support your positioning.

International registration also requires attention if you plan to sell globally. Each region has its own registration databases (the US has no centralized registry, but the FDA maintains an optional cosmetic facility listing; the EU has the CPNP; Canada has a cosmetic product filing system; and Australia's TGA maintains a database of registered therapeutic goods). If you are sourcing from a contract manufacturer, they may handle some of these registrations, but you remain liable for accuracy and compliance. When selecting a chemist or co-packer through AJ Cosmo Labs, ask explicitly about their experience with microbiome product compliance in your target markets; a chemist who has navigated probiotic cosmetic regulations in the EU or Canada brings valuable guidance.

A critical piece of advice: before you invest heavily in formulation and manufacturing, work with your chemist or a regulatory consultant to define your claim strategy and regulatory pathway. A minor change in how you describe your product ("supports scalp microbiome" vs. "treats microbiome imbalance") can shift you from cosmetic to drug classification, dramatically increasing your compliance burden and time to market. Some founders discover this too late, after they have already formulated and manufactured a product that cannot legally make the claims they intended to use in marketing. Clarifying this upfront—ideally in your chemist brief—saves money and heartache.

Read the full guide on How to Find a Haircare Chemist for Scalp Microbiome Products →

More about How to Find a Haircare Chemist for Scalp Microbiome Products

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app